Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.
Publication
, Journal Article
Griffith, LM; Pavletic, SZ; Tyndall, A; Bredeson, CN; Bowen, JD; Childs, RW; Gratwohl, A; van Laar, JM; Mayes, MD; Martin, R; McSweeney, PA ...
Published in: Biol Blood Marrow Transplant
November 2005
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Biol Blood Marrow Transplant
DOI
ISSN
1083-8791
Publication Date
November 2005
Volume
11
Issue
11
Start / End Page
862 / 870
Location
United States
Related Subject Headings
- United States
- Transplantation, Homologous
- National Institutes of Health (U.S.)
- Immunology
- Humans
- Hematopoietic Stem Cell Transplantation
- Education
- Clinical Trials as Topic
- Clinical Protocols
- Autoimmune Diseases
Citation
APA
Chicago
ICMJE
MLA
NLM
Griffith, L. M., Pavletic, S. Z., Tyndall, A., Bredeson, C. N., Bowen, J. D., Childs, R. W., … Workshop participants, . (2005). Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005. Biol Blood Marrow Transplant, 11(11), 862–870. https://doi.org/10.1016/j.bbmt.2005.07.009
Griffith, Linda M., Steven Z. Pavletic, Alan Tyndall, Christopher N. Bredeson, James D. Bowen, Richard W. Childs, Alois Gratwohl, et al. “Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.” Biol Blood Marrow Transplant 11, no. 11 (November 2005): 862–70. https://doi.org/10.1016/j.bbmt.2005.07.009.
Griffith LM, Pavletic SZ, Tyndall A, Bredeson CN, Bowen JD, Childs RW, et al. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005. Biol Blood Marrow Transplant. 2005 Nov;11(11):862–70.
Griffith, Linda M., et al. “Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.” Biol Blood Marrow Transplant, vol. 11, no. 11, Nov. 2005, pp. 862–70. Pubmed, doi:10.1016/j.bbmt.2005.07.009.
Griffith LM, Pavletic SZ, Tyndall A, Bredeson CN, Bowen JD, Childs RW, Gratwohl A, van Laar JM, Mayes MD, Martin R, McSweeney PA, Muraro PA, Openshaw H, Saccardi R, Sandmaier BM, Forman SJ, Nash RA, Workshop participants. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005. Biol Blood Marrow Transplant. 2005 Nov;11(11):862–870.
Published In
Biol Blood Marrow Transplant
DOI
ISSN
1083-8791
Publication Date
November 2005
Volume
11
Issue
11
Start / End Page
862 / 870
Location
United States
Related Subject Headings
- United States
- Transplantation, Homologous
- National Institutes of Health (U.S.)
- Immunology
- Humans
- Hematopoietic Stem Cell Transplantation
- Education
- Clinical Trials as Topic
- Clinical Protocols
- Autoimmune Diseases